Lawrence T Goodnough

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Detection, evaluation, and management of anemia in the elective surgical patient
    Lawrence T Goodnough
    Department of Pathology, Stanford University Medical Center, 300 Pasteur Drive H 1402, Stanford, CA 94305 5626, USA
    Anesth Analg 101:1858-61. 2005
  2. doi request reprint Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients
    Magali J Fontaine
    Department of Pathology, Stanford Hospital and Clinics, Stanford University, Stanford, California 94305 5626, USA
    Transfusion 51:2611-8. 2011
  3. doi request reprint Improving platelet supply chains through collaborations between blood centers and transfusion services
    Magali J Fontaine
    Department of Pathology, Stanford University Medical Center, Stanford, California 94305 5626, USA
    Transfusion 49:2040-7. 2009
  4. doi request reprint Impact of cytomegalovirus (CMV) antibody reflex testing in the transfusion service on management of CMV-seronegative blood inventory
    Magali J Fontaine
    Department of Pathology, Stanford University, and Stanford Hospital and Clinics, Stanford, California, USA
    Transfusion 50:1685-9. 2010
  5. doi request reprint Quality management in the transfusion service: case studies in process improvement
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, Stanford University Medical Center, Stanford, California 94305, USA
    Transfusion 51:600-9. 2011
  6. ncbi request reprint Blood and blood conservation: a national perspective
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Cardiothorac Vasc Anesth 18:6S-11S. 2004
  7. doi request reprint How we treat: transfusion medicine support of obstetric services
    Lawrence T Goodnough
    Department of Pathology and Medicine and Obstetrics and Anesthesiology, Stanford University School of Medicine, Stanford, California 94305, USA
    Transfusion 51:2540-8. 2011
  8. ncbi request reprint Autologous blood donation
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, H 1402, Stanford, CA 94305 5626, USA
    Anesthesiol Clin North America 23:263-70, vi. 2005
  9. ncbi request reprint Risks of blood transfusion
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, H 1402 Stanford, CA 94305 5324, USA
    Anesthesiol Clin North America 23:241-52, v. 2005
  10. ncbi request reprint Improved blood utilization using real-time clinical decision support
    Lawrence T Goodnough
    Department of Pathology, Stanford University, Stanford, California Department of Medicine, Stanford University, Stanford, California
    Transfusion 54:1358-65. 2014

Collaborators

Detail Information

Publications43

  1. ncbi request reprint Detection, evaluation, and management of anemia in the elective surgical patient
    Lawrence T Goodnough
    Department of Pathology, Stanford University Medical Center, 300 Pasteur Drive H 1402, Stanford, CA 94305 5626, USA
    Anesth Analg 101:1858-61. 2005
    ....
  2. doi request reprint Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients
    Magali J Fontaine
    Department of Pathology, Stanford Hospital and Clinics, Stanford University, Stanford, California 94305 5626, USA
    Transfusion 51:2611-8. 2011
    ..We hypothesized that the C1q-SAB method might be more relevant than the IgG-SAB method because the antibodies identified may activate the complement cascade causing PLT destruction...
  3. doi request reprint Improving platelet supply chains through collaborations between blood centers and transfusion services
    Magali J Fontaine
    Department of Pathology, Stanford University Medical Center, Stanford, California 94305 5626, USA
    Transfusion 49:2040-7. 2009
    ....
  4. doi request reprint Impact of cytomegalovirus (CMV) antibody reflex testing in the transfusion service on management of CMV-seronegative blood inventory
    Magali J Fontaine
    Department of Pathology, Stanford University, and Stanford Hospital and Clinics, Stanford, California, USA
    Transfusion 50:1685-9. 2010
    ..Our goal is to minimize unnecessary cytomegalovirus (CMV)-seronegative blood transfusion to preserve the CMV-seronegative blood inventory for patients who are identified as CMV seronegative...
  5. doi request reprint Quality management in the transfusion service: case studies in process improvement
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, Stanford University Medical Center, Stanford, California 94305, USA
    Transfusion 51:600-9. 2011
    ..Laboratory-based quality improvement (QI) initiatives can improve clinical outcomes and patient safety...
  6. ncbi request reprint Blood and blood conservation: a national perspective
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Cardiothorac Vasc Anesth 18:6S-11S. 2004
  7. doi request reprint How we treat: transfusion medicine support of obstetric services
    Lawrence T Goodnough
    Department of Pathology and Medicine and Obstetrics and Anesthesiology, Stanford University School of Medicine, Stanford, California 94305, USA
    Transfusion 51:2540-8. 2011
    ..Obstetric services depend on the transfusion service (TS) to provide diagnostic testing and blood component therapy for clinical care pathways...
  8. ncbi request reprint Autologous blood donation
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, H 1402, Stanford, CA 94305 5626, USA
    Anesthesiol Clin North America 23:263-70, vi. 2005
    ..Nevertheless, the continuing emergence of new pathogens and the potential for severe blood inventory shortages continue to give preoperative autologous blood donation an important role in blood conservation strategies...
  9. ncbi request reprint Risks of blood transfusion
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, H 1402 Stanford, CA 94305 5324, USA
    Anesthesiol Clin North America 23:241-52, v. 2005
    ..Pathogen inactivation technologies and reactive strategies such as nucleic acid testing ensure continued advances in blood safety...
  10. ncbi request reprint Improved blood utilization using real-time clinical decision support
    Lawrence T Goodnough
    Department of Pathology, Stanford University, Stanford, California Department of Medicine, Stanford University, Stanford, California
    Transfusion 54:1358-65. 2014
    ..We analyzed blood utilization at Stanford Hospital and Clinics after implementing real-time clinical decision support (CDS) and best practice alerts (BPAs) into physician order entry (POE) for blood transfusions...
  11. ncbi request reprint Logistics of transfusion support for patients with massive hemorrhage
    Lawrence T Goodnough
    Department of Pathology, Stanford University, Stanford, California, USA
    Curr Opin Anaesthesiol 26:208-14. 2013
    ..The review summarizes practical approaches for transfusion support of patients with massive hemorrhage...
  12. doi request reprint Concepts of blood transfusion in adults
    Lawrence T Goodnough
    Department of Pathology, Stanford University, Stanford, CA, USA
    Lancet 381:1845-54. 2013
    ..Nevertheless, institutional experience and national databases suggest that a restrictive blood transfusion approach is being increasingly implemented as best practice...
  13. doi request reprint Implementation of a two-specimen requirement for verification of ABO/Rh for blood transfusion
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305 5626, USA
    Transfusion 49:1321-8. 2009
    ..This study presents our implementation of a two-specimen requirement with no prior record of ABO/Rh to verify patients' blood type before transfusion...
  14. pmc Massive transfusion protocols for patients with substantial hemorrhage
    Pampee P Young
    Department of Pathology, Vanderbilt University School of Medicine, 1161 21st Ave South, C2217A MCN, Nashville, TN 37232, USA
    Transfus Med Rev 25:293-303. 2011
    ..However, the use of MTPs remains controversial. This review describes published experiences with MTPs and illustrates the potential value of several MTPs currently utilized by academic transfusion services...
  15. doi request reprint Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion
    Erik J Uhlmann
    Transfusion Medicine and Pheresis Unit, Beth Israel Deaconess Medical Center, Boston, Massachusetts Departments of Hematology, Oncology and Bone Marrow Transplant, St Louis Children s Hospital, St Louis, Missouri Departments of Pathology and Medicine, Stanford University Medical Center, Stanford, California
    Transfusion 54:384-8. 2014
    ..Hyperhemolysis syndrome is a serious transfusion reaction mostly reported in association with sickle cell disease, characterized by destruction of both donor and host red blood cells (RBCs) by an unknown mechanism...
  16. doi request reprint Blood ordering from the operating room: turnaround time as a quality indicator
    Colt M McClain
    Department of Veterans Affairs Medical Center, Nashville, Tennessee, USA
    Transfusion 53:41-8. 2013
    ..We examined the TAT for issuing RBCs from the blood bank to the operating rooms (ORs) at Vanderbilt University Medical Center (VUMC) and Stanford University Medical Center (SUMC)...
  17. ncbi request reprint Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients
    Scott D Boyd
    Department of Pathology, Stanford University, and Department of Transfusion Medicine, Stanford University Hospitals and Clinics, CA 94305, USA
    Liver Transpl 13:1654-61. 2007
    ..Our findings suggest that blood transfusion and immune modulation greatly affect the survival of patients after liver transplantation...
  18. doi request reprint Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting
    Aaron C Logan
    Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Hematology Am Soc Hematol Educ Program 2010:153-9. 2010
    ..We review the evidence regarding the efficacy and safety of this important, but controversial, hemostatic agent in the off-label setting...
  19. doi request reprint A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia
    Jane E Onken
    Duke Clinical Research Institute, Durham, North Carolina Luitpold Pharmaceuticals, Inc, Norristown, Pennsylvania Albert Einstein College of Medicine, New York, New York Stanford University School of Medicine, Stanford, California Webb Writes, LLC, Durham, North Carolina Gainesville Hematology Oncology Associates, Gainesville, Florida Northeast OB GYN Associates, San Antonio, Texas Wake Gastroenterology, Wake Research Associates, Raleigh, North Carolina Medical Oncology Care Associates, Orange, California Grossmont Center for Clinical Research, La Mesa, California Department of Pathology, Stanford University School of Medicine, Stanford, California
    Transfusion 54:306-15. 2014
    ..Ferric carboxymaltose (FCM), a nondextran IV formulation, permits larger single doses...
  20. doi request reprint Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis
    Lawrence T Goodnough
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305 5626, USA
    J Thorac Cardiovasc Surg 145:1077-1082.e4. 2013
    ..The objective of the present study was to characterize a potential risk-adjusted difference in transfusion requirements between prasugrel and clopidogrel cohorts...
  21. doi request reprint Age of blood as a limitation for transfusion: potential impact on blood inventory and availability
    Magali J Fontaine
    Department of Pathology, Stanford University School of Medicine, Stanford University Medical Center, 300 Pasteur Drive, Room H1402, M C 5626, Stanford, CA 94305 5626, USA
    Transfusion 50:2233-9. 2010
    ..Evolving concerns about storage lesions for red blood cells (RBCs) have led to ongoing trials evaluating the benefits of transfusing fresher blood to acutely ill patients...
  22. ncbi request reprint Recombinant factor VIIa: safety and efficacy
    Lawrence T Goodnough
    Department of Pathology and Medicine, Stanford University, Stanford, California 94305 5626, USA
    Curr Opin Hematol 14:504-9. 2007
    ..Recombinant factor VIIa has been increasingly used to provide hemostasis in nonapproved indications. This trend has resulted in concerns about safety, efficacy and costs...
  23. ncbi request reprint Blood management
    Lawrence T Goodnough
    Department of Pathology and Medicine, Stanford University Medical Center, 300 Pasteur Dr, M C 5626, Stanford, CA 94305, USA
    Arch Pathol Lab Med 131:695-701. 2007
    ..We provide an overview of the principles of blood management: the appropriate use of blood and blood components, with a goal of minimizing their use...
  24. doi request reprint Rationale for blood conservation
    Lawrence T Goodnough
    Department of Pathology and Medicine, Transfusion Service, Stanford University Medical Center, Stanford, California 94305 5626, USA
    Surg Infect (Larchmt) 6:S3-8. 2005
    ..Exposure of patients to allogeneic blood transfusion can be minimized or avoided by the systematic use of multiple blood conservation techniques. Current use of these technologies is variable...
  25. ncbi request reprint Evolution in alternatives to blood transfusion
    Lawrence T Goodnough
    Washington University School of Medicine, St Louis, MO 63110, USA
    Hematol J 4:87-91. 2003
  26. ncbi request reprint Bloodless medicine: clinical care without allogeneic blood transfusion
    Lawrence T Goodnough
    Washington University School of Medicine, St Louis, Missouri, USA
    Transfusion 43:668-76. 2003
  27. ncbi request reprint Risks of blood transfusion
    Lawrence T Goodnough
    Department of Medicine, Washington University School of Medicine, St Louis, MO 63110 1093, USA
    Crit Care Med 31:S678-86. 2003
    ..To review the current status of risks of blood transfusion...
  28. pmc Autologous blood donation
    Lawrence T Goodnough
    Washington University School of Medicine, Transfusion Services, Barnes Jewish Hospital, St Louis, Missouri, USA
    Crit Care 8:S49-52. 2004
    ..It has been determined that preoperative autologous blood donation is poorly cost-effective; the use of this procedure must be based on evidence that it is safe and of value for the patient...
  29. ncbi request reprint Anemia of chronic disease
    Guenter Weiss
    Department of General Internal Medicine, Clinical Immunology and Infectious Diseases, Medical University of Innsbruck, Innsbruck, Austria
    N Engl J Med 352:1011-23. 2005
  30. ncbi request reprint Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature
    Susan D Ross
    MetaWorks, Inc, Medford, Massachusetts 02155, USA
    Clin Ther 28:801-31. 2006
    ..Evidence-based guidelines and systematic reviews of the management of CIA do not yet include all currently approved ESPs or all of the clinically relevant benefits and risks of ESPs...
  31. ncbi request reprint Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation
    Ravi Vij
    Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St Louis, MO 63110 1093, USA
    Blood 101:2067-9. 2003
    ..This knowledge may help expand the donor pool in areas with a high prevalence of CMV in the general population...
  32. ncbi request reprint Issues in the management of cancer-related thrombocytopenia
    Lawrence T Goodnough
    Departments of Medicine and Pathology and Immunology, Divisions of Laboratory Medicine and Oncology, Washington University School of Medicine, St Louis, Missouri 63110 1093, USA
    Oncology (Williston Park) 16:1558-67; discussion 1570, 1572-4. 2002
    ..These agents include recombinant human interleukin-11, recombinant human thrombopoietin, and c-Mpl ligand mimetics...
  33. ncbi request reprint The rise and fall of preoperative autologous blood donation (editorial). Transfusion. 2001;41:1459-62
    Mark E Brecher
    University of North Carolina HospitalsChapel Hill, NC 27514e mail Louis, MO
    Transfusion 42:1618-22. 2002
  34. ncbi request reprint Transfusion medicine: looking to the future
    Lawrence T Goodnough
    Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Lancet 361:161-9. 2003
    ..Finally, serious difficulties in blood safety and availability for poor, developing countries require innovative strategies and commitment of resources...
  35. ncbi request reprint Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII
    Jack D Bui
    Department of Pathology and Immunology, Washington University School of Medicine, 660 S Euclid, St Louis, MO 63110, USA
    J Thorac Cardiovasc Surg 124:852-4. 2002
  36. ncbi request reprint Update on transfusion medicine
    Aryeh Shander
    Department of Anesthesiology and Critical Care and Hyperbaric Medicine and the New Jersey Institute for the Advancement of Bloodless Medicine and Surgery, Englewood Hospital and Medical Center, Englewood, New Jersey 07631, USA
    Pharmacotherapy 27:57S-68S. 2007
    ..The benefits, risks, and several ongoing controversies that relate to the appropriateness and safety of blood product use are also summarized...
  37. ncbi request reprint Anemia: not just an innocent bystander?
    Allen R Nissenson
    Arch Intern Med 163:1400-4. 2003
  38. ncbi request reprint Red cell growth factors in patients with chronic anemias
    Lawrence T Goodnough
    Division of Laboratory Medicine, Washington University School of Medicine, Box 8118, 660 S Euclid Avenue, St Louis, MO 63110, USA
    Curr Hematol Rep 1:119-23. 2002
    ....
  39. ncbi request reprint The use of erythropoietin to increase red cell mass
    Lawrence T Goodnough
    Division of Laboratory Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Can J Anaesth 50:S10-8. 2003
  40. ncbi request reprint Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?
    Pampee P Young
    Department of Pathology and Immunology, Washington University School of Medicine, MO 63110, USA
    Transfusion 44:67-72. 2004
    ..The development of RBC autoantibodies resulting from or associated with allogeneic blood transfusions (i.e., RBC autoimmunization) is not a well-recognized complication of RBC transfusions...
  41. ncbi request reprint Objectives and limitations of bloodless medical care
    Aryeh Shander
    Department of Anesthesiology and Critical Care and Hyperbaric Medicine, New Jersey Institute for the Advancement of Bloodless Medicine and Surgery, Englewood Hospital and Medical Center, Englewood, NJ 07631, USA
    Curr Opin Hematol 13:462-70. 2006
    ..To outline the rationale, limitations, and execution of bloodless medical and surgical programs, highlighting characteristics that contribute to successful outcomes...
  42. ncbi request reprint Anemia screening in elective surgery: definition, significance and patients' interests
    Aryeh Shander
    Anesth Analg 103:778-9; author reply 779-80. 2006
  43. ncbi request reprint Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial
    Jerrold H Levy
    Emory University Hospital, Atlanta, GA, USA
    J Thorac Cardiovasc Surg 124:35-42. 2002
    ..This study examined the hypothesis that a hemoglobin-based oxygen-carrying solution can serve as an initial alternative to red blood cell transfusion...